Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS)

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 38ab16d978e386c76ce48824e1934d91339c833c
First added on: Jan 17, 2026